• SENSEX 75,364.69
    -930.67 (--1.22%)
  • BANKNIFTY 51,502.70
    -94.65 (--0.18%)

IPO

Explore our secure online trading, IPO bidding, mutual fund investments, and depository services, all designed to provide seamless transactions, expert insights, and real-time market access for smart investing

Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Ltd

    Registered Office : Sun Magnetica 5th Floor,Nr LIC Serivce Road Louiswadi,Thane Maharashtra 400604 Phone : 91-22-41703200
    Fax : 91-22-25835159

    Email : sanjay@advancedenzymes.com; info@advancedenzymes.c

    Website : www.advancedenzymes.com

Initial public offer of upto 4,594,875 Equity shares of face value of Rs. 10 each ("equity shares") of Advanced Enzyme Technologies Limited (The "company" Or the "issuer") for cash at a price of Rs. 896 per equity share (including a share premium of Rs. 886 per equity share) aggregating to Rs. 411.49 Crores (the "offer") Consisting of a fresh issue of 560,405 equity shares aggregating to Rs. 50 Crores (the "fresh issue") and an offer for sale of, to 4,00,000 Equity shares by chandrakant Rathi Innovations and Projects Private Limited, 50,000 equity shares by Kishor Laxminarayan Rathi, 30,000 equity shares by Mangala Madhusudan Kabra, 17,00,000 equity shares by Vasant Laxminarayan Rathi, 5,00,000 equity shares by the Vasant and Prabha Rathi Generation Trust, (Collectively the "Promoter group selling shareholders") and 17,900 equity shares by Kotak Employees Investment Trust, 1,62,700 equity shares by Kotak India Venture Fund I and 3,36,600 equity shares by Kotak India Venture (offshore) fund (collectively the "Investor selling shareholders") and 447,270 equity shares by Persons listed in Annexure `A' (collectively The "Other selling shareholders-I") and 40,000 equity shares by Mukund Madhusudan Kabra, 3,50,000 equity shares by Pradip Bhailal Shah (collectively the "other selling shareholders-II") aggregating Rs. 361.49 Crores ("offer for sale"), and together with the fresh issue (the "offer"). The offer comprises a net offer to the public of 4,570,184 equity shares (The "net offer") and reservation of 24,691 equity shares aggregating Rs. 2 Crores for subscription by Eligible employees (As defined herein) not exceeding 5% of the post-offer paid-up equity shares capital (the "employee reservation portion"). Offer Price : Rs. 896* per equity share of face value of Rs. 10 each. *A Discount of Rs. 86 per equity share (Equivalent to 9.60%) on the offer price has been offered to eligible employees anchor investor offer price: Rs. 896 per equity share the offer price is 89.6 times the face value.

Issue

Opens On

Closes On

20-Jul-2016

22-Jul-2016

Money Payable On

Application

Allotment

896.00

0.00

Minimum Application for shares in Nos : 16.0 Further Multiples of : 16.0

₹Cr

Lead Managers to the Issue

Project Cost (₹.Cr)

Project Financed through Current Offer (₹.Cr)

Post Issue Equity Share Capital (₹.Cr)

Issue Price (₹.Cr)

0.00

411.49

0.00

896.00

Axis Capital Ltd

ICICI Securities Ltd

Projects
  • Investment in Advanced Enzymes USA, WOS
Promoted By
  • Vasant Laxminarayan Rathi
  • Chandrakant Laxminarayan Rathi
Listing At
  • BSE
  • NSE
Registrar to the Issue
  • Link Intime India Pvt Ltd